Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations M. N. AbbasS. KausarH. Cui Review Article 19 October 2019 Pages: 963 - 977
Li–Fraumeni syndrome heterogeneity P. GargalloY. YáñezA. Cañete Review Article 05 November 2019 Pages: 978 - 988
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology P. GarridoE. CondeF. López-Ríos Special Article Open access 09 October 2019 Pages: 989 - 1003
Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience M. GhidiniB. M. DonidaG. Tomasello Research Article 10 October 2019 Pages: 1004 - 1012
Baicalein, an enteric microbial metabolite, suppresses gut inflammation and cancer progression in ApcMin/+ mice C.-Z. WangC.-F. ZhangC.-S. Yuan Research Article 24 October 2019 Pages: 1013 - 1022
Calcium-sensing receptor bridges calcium and telomerase reverse transcriptase in gastric cancers via Akt R. XieB. TuoJ. Xu Research Article 24 October 2019 Pages: 1023 - 1032
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials G. RovielloM. R. Gatta MicheletE. Mini Research Article 15 October 2019 Pages: 1033 - 1039
Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+ 4/CD44+ prostate cancer stem cells Z. BinalE. AçıkgözB. Altay Research Article 19 October 2019 Pages: 1040 - 1048
Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain M. A. SeguiJ. J. CruzM. Martin Research Article Open access 08 November 2019 Pages: 1049 - 1058
Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides K. V. ArgyropoulosM. PulitzerM. Siakantaris Research Article 06 November 2019 Pages: 1059 - 1066
Prognostic value of peptidyl-prolyl cis–trans isomerase 1 (PIN1) in human malignant tumors S. G. KhoeiC. MohammadiR. Najafi Research Article 14 November 2019 Pages: 1067 - 1077
Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy M. ArenasS. Fernández-ArroyoJ. Joven Research Article 02 November 2019 Pages: 1078 - 1085
Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma T. XieJ.-R. WangQ. Huang Research Article 01 November 2019 Pages: 1086 - 1093
Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models G. S. ShuklaS. C. PeroD. N. Krag Research Article 16 November 2019 Pages: 1094 - 1104
Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer Y. XuM. Zhu Research Article 14 November 2019 Pages: 1105 - 1116
Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer P. SitthideatphaiboonS. SantisukwongchoteV. Sriuranpong Research Article 21 November 2019 Pages: 1117 - 1125
PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer H. IgarashiH. TaniguchiH. Nakase Research Article 18 November 2019 Pages: 1126 - 1137
Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth A. DasM. AlshareefD. Cachia Research Article 15 November 2019 Pages: 1138 - 1145
The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis S.-Y. ZhengH.-J. CuiX. Jiang Research Article Open access 20 November 2019 Pages: 1146 - 1154
Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model N. E. El-AshmawyM. L. SalemA. O. Ibrahim Research Article 20 November 2019 Pages: 1155 - 1165
HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer A. D. Lázaro-SánchezP. Salces-OrtizA. Juárez-Marroquí Research Article 20 November 2019 Pages: 1166 - 1171
The prognostic role of FZD6 in esophageal squamous cell carcinoma patients J. ZhangJ.-L. WangY.-Y. Wang Research Article 20 November 2019 Pages: 1172 - 1179
Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM) P. Saez-CarlinA. García-BotellaA. J. Torres García Research Article 22 November 2019 Pages: 1180 - 1186
Spanish validation of Charlson index applied to prostate cancer F. Casas DuranI. ValduviecoF. Ferrer Research Article 20 November 2019 Pages: 1187 - 1192
Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome M. K. SinghL. SinghS. Kashyap Research Article 25 November 2019 Pages: 1193 - 1204